Skip to content

Clinical trials

Bile Duct Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bile Duct Neoplasms Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20131
20141
20171
20181
20191
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University College, London2
AstraZeneca1
Basilea Pharmaceutica1
BioNTech SE1
Forma Therapeutics, Inc.1
Helsinn Healthcare SA1
Merck Sharp & Dohme LLC1
PCI Biotech AS1
University Hospital Plymouth NHS Trust1
University Hospital Southampton NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bile Duct Neoplasms12
Cholangiocarcinoma7
Gallbladder Neoplasms6
Biliary Tract Neoplasms3
Liver Neoplasms2
Pancreatic Neoplasms2
Carcinoma, Hepatocellular1
Carcinoma, Pancreatic Ductal1
Colorectal Neoplasms1
Endometrial Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.